Nunn Jason Raleigh 4
4 · Zenas BioPharma, Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Nunn Jason Raleigh
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-10+18,500→ 18,500 totalExercise: $11.94Exp: 2035-06-10→ Common Stock (18,500 underlying)
Footnotes (1)
- [F1]The option vests as to 100% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, subject to continued service.